{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:04:30Z","timestamp":1759421070680},"reference-count":28,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ejps.2009.03.004","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T14:47:10Z","timestamp":1237819630000},"page":"351-362","source":"Crossref","is-referenced-by-count":7,"title":["Novel farnesylthiosalicylate (FTS)-eluting composite structures"],"prefix":"10.1016","volume":"37","author":[{"given":"Amir","family":"Kraitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meital","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2009.03.004_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(99)00173-X","article-title":"Biodegradable semi-crystalline comb polyesters influence the microsphere production by means of a supercritical fluid extraction technique (ASES)","volume":"63","author":"Breitenbach","year":"2000","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1540-8183.2006.00198.x","article-title":"Polymers, drug release, and drug-eluting stents","volume":"19","author":"Commandeur","year":"2006","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ejps.2009.03.004_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.RES.86.8.879","article-title":"Arterial paclitaxel distribution and deposition","volume":"86","author":"Creel","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejps.2009.03.004_bib4","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0735-1097(00)01020-2","article-title":"Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months","volume":"36","author":"Drachman","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2009.03.004_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","article-title":"Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers","volume":"71","author":"Feng","year":"2001","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.CIR.0000050367.65079.71","article-title":"Local drug delivery via a coronary stent with programmable release pharmacokinetics","volume":"107","author":"Finkelstein","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2009.03.004_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-3659(02)00212-2","article-title":"Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity","volume":"83","author":"Fonseca","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.ATV.0000112021.98971.f0","article-title":"Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor","volume":"24","author":"George","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2009.03.004_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1540-8183.2004.04040.x","article-title":"Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials","volume":"17","author":"Halkin","year":"2004","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ejps.2009.03.004_bib10","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2009.03.004_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","article-title":"Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation","volume":"27","author":"Hofma","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejps.2009.03.004_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.06.025","article-title":"Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel","volume":"283","author":"Jackson","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2009.03.004_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2004.04.004","article-title":"Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugs","volume":"14","author":"Kloog","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejps.2009.03.004_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2007.11.011","article-title":"Long-term in vitro study of paclitaxel-eluting bioresorbable core\/shell fiber structures","volume":"126","author":"Kraitzer","year":"2008","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2009.03.004_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.fjc.0000246940.91191.1f","article-title":"Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery","volume":"48","author":"Li","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2009.03.004_bib17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0142-9612(00)00047-8","article-title":"In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams","volume":"21","author":"Lu","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2009.03.004_bib18","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2009.03.004_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1568016054368160","article-title":"Stent-based delivered anti-proliferative drugs in the prevention of coronary stent restenosis","volume":"3","author":"Moreno","year":"2005","journal-title":"Curr. Med. Chem. Cardiovasc. Hematol. Agents"},{"key":"10.1016\/j.ejps.2009.03.004_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jbm.a.30188","article-title":"Physical characterization of controlled release of paclitaxel from the TAXUS express 2 drug-eluting stent","volume":"71","author":"Ranade","year":"2004","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejps.2009.03.004_bib21","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.amjcard.2005.11.081","article-title":"On-versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])","volume":"97","author":"Rao","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejps.2009.03.004_bib22","first-page":"S9","article-title":"Optimal stent design for drug delivery","volume":"5","author":"Rogers","year":"2004","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ejps.2009.03.004_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2005.03.069","article-title":"The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)","volume":"46","author":"Serruys","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2009.03.004_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2007.04.022","article-title":"Release profiles in drug-eluting stents: issues and uncertainties","volume":"120","author":"Venkatraman","year":"2007","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2009.03.004_bib26","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.biomaterials.2006.07.016","article-title":"Controlled release of sirolimus from a multilayered PLGA stent matrix","volume":"27","author":"Wang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2009.03.004_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2005.12.012","article-title":"Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings","volume":"111","author":"Westedt","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2009.03.004_bib28","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1016\/j.biomaterials.2004.01.038","article-title":"In vitro degradation of three-dimensional porous poly(d,l-lactide-co-glycolide) scaffolds for tissue engineering","volume":"25","author":"Wu","year":"2004","journal-title":"Biomaterials"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098709000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098709000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T23:22:38Z","timestamp":1545348158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098709000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":28,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0928098709000797"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2009.03.004","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}